title: [Stevens-Johnson syndrome and toxoplasmic choroiditis].
authors.forename: G
authors.initials: G
authors.lastname: Mimoun
authors.forename: M
authors.initials: M
authors.lastname: Binaghi
authors.forename: E
authors.initials: E
authors.lastname: Albengres
authors.forename: G
authors.initials: G
authors.lastname: Chaine
authors.forename: M
authors.initials: M
authors.lastname: Koso
authors.forename: P
authors.initials: P
authors.lastname: Saiag
authors.forename: G
authors.initials: G
authors.lastname: Coscas
authors.forename: J P
authors.initials: JP
authors.lastname: Tillement
mesh_terms: D000328:Adult; D002648:Child; D002833:Choroiditis / Q000188:drug therapy*; D004359:Drug Therapy, Combination; D005260:Female; D006801:Humans; D008297:Male; D011739:Pyrimethamine / Q000009:adverse effects; D013262:Stevens-Johnson Syndrome / Q000139:chemically induced*; D013411:Sulfadiazine / Q000009:adverse effects; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy*
chemical_list: D013411:Sulfadiazine; D011739:Pyrimethamine
vernacular_title: Syndrome de Stevens-Johnson et choroïdite toxoplasmique.